MedTrace Logo

Effect of Intranasal Insulin on Cognitive Processes and Appetite

NCT03632681 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2019-05-02

No results posted yet for this study

Summary

This study investigates the effect of intranasal insulin on cognitive processes (behavioural and neural) in healthy lean and obese female adults. All subjects will receive a single-dose of intranasal insulin and/or placebo (on different days) before participating in several cognitive tasks.

Conditions

Interventions

DRUG

Intranasal Insulin

Intranasal insulin

DRUG

Intranasal Placebo

Intranasal placebo manufactured to mimic smell of insulin

Sponsors & Collaborators

  • Queen Elizabeth Hospital NHS Foundation Trust

    collaborator OTHER

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Maartje SPetter, PhD · Univerisity of Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-23
Primary Completion
2019-04-01
Completion
2019-04-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03632681 on ClinicalTrials.gov